Cefuroxime
In clinical developmentAlso known as Ceftin, Cefuroxime Axetil, Cephuroxime, Zinacef+5 more
Ceftin, Cefuroxime Axetil, Cephuroxime, Zinacef, Cefuroxim, Cefuroxima, Cefuroximo, Cefuroxime Sodium, Cefuroximum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Comparing Placebo Versus Antibiotics for Acute Uncomplicated Diverticulitis
Clinical Trial Comparing Oral Versus Intravenous Cefuroxime in Pregnant Women with Pyelonephritis
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Clinical Trial Comparing Oral Versus Intravenous Cefuroxime in Pregnant Women with Pyelonephritis
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes3
Journals, researchers & institutions
- Journal of cataract and refractive surgery1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Cefuroxime in the shared literature.
Studied across 3 of the same disease areas as Cefuroxime in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials